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doi:10.1016/j.jtcvs.2004.04.032562 The Journal of Thoracic and CardioObjective: Reduction ascending aortoplasty is a controversial procedure. Some
believe that it can be appropriately applied when the anatomic features are favor-
able. Others suggest that it should be restricted to those patients who are at
unacceptably high risk for more radical procedures, and there are also those who
believe that reduction ascending aortoplasty should not be applied at all. The
purpose of the article is to draw conclusions on the applicability of reduction
ascending aortoplasty in modern cardiovascular surgery.
Methods: The issue was examined in the mirror of the authors’ own experiences, by
review and scrutiny of the literature available on the subject, and by conducting an
extensive survey of the profession.
Results: We found that given proper indications (ie, poststenotic dilatations of 6
cm in diameter, absence of cystic medial necrosis, and a technique that decreases
aortic diameter to 3.5 cm), nonreinforced reduction ascending aortoplasty per-
formed concomitantly with aortic valve replacement appears to be a simple and safe
procedure, with low morbidity and mortality and rare late complications. External
reinforcement might extend the scope of indication for reduction ascending aorto-
plasty to ascending aortic aneurysms associated with aortic regurgitation and to
those with primary structural aortic wall disease with comparable results. Experi-
ence also has shown that late complications might be further reduced by means of
proper proximal anchoring and extending the wrap past the origin of the innominate
artery.
Conclusions: We conclude that reduction ascending aortoplasty is certainly alive.
Although it does not appear to be an extremely popular operation, about half of the
surgeons who responded believe it to be justified. Regardless of which modality is
used, lifetime monitoring of ascending aortic size is essential and so advised.
Because of recent sporadic reports of “under-the-wrap” aortic wall atrophy and
rupture, the issue of reinforcement of reduction ascending aortoplasty requires
continued re-evaluation.
Differences in anatomy may require different techniques.
—Thierry Carrel, 19911
Reduction ascending aortoplasty (RAA) is a controversial operation.Some believe that it can be appropriately applied when the ana-tomic features are favorable. Others suggest that it should berestricted to those patients who are at unacceptably high risk formore radical procedures, and there are also those who believe thatRAA should not be applied at all. The purpose of this article is to
examine the subject in the mirror of our own experiences, by reviewing related
literature, and by conducting an extended survey of the profession and to draw
conclusions on the applicability of RAA in modern cardiovascular surgery.
Background
The integrity of the aortic wall depends on its holding power, as defined by its biologic
properties and by the mural stress acting upon it. The latter is proportional with the diameter
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CDof the aorta and the blood pressure within and relates inversely to
the thickness of its wall. Depending on these factors,2 ascending
aortic aneurysms (AscAs) are expected to expand gradually, the
risk of eventual rupture at a diameter of 5 to 6 cm is a yearly 6.5%,
and the major adverse event rate (rupture, dissection, or death) is
expected to be 14% per year.3 The data strongly support a pre-
emptive surgical approach intended to lessen mural stress, either
by means of graft replacement or, in selected cases, by means of
the more conservative approach of RAA. Such a need to address
the dilated ascending aorta is encountered in 5% to 15% of all
patients undergoing aortic valve surgery.1
The differences between AscAs and aortic aneurysms at other
locations are significant. AscAs are especially common in patients
with aortic stenosis4-6; however, they can also occur in those with
clinically normal congenitally bicuspid aortic valves.7 Although
the prevalent view today is that the same inborn defect that causes
bicuspid valve anomaly might lead to ascending aortic wall weak-
ness as well,8,9 our recent studies indicate that congenitally bicus-
pid valves, even if asymptomatic and with no appreciable pressure
gradient, are morphologically stenotic enough to generate signif-
icant turbulence and cause poststenotic aneurysmal dilatation.7
Patients with cystic medial necrosis also frequently have AscAs.
Most AscAs are less than 6 cm in diameter, convex to the right,
either fusiform symmetrical or slanted to the right, and easy to
isolate. Their lining is smooth and without atheromas,6 the wall is
thin or of normal thickness, the layers are recognizable, and mural
clots are notably absent. Dissections occur frequently, but rupture
without dissection is relatively rare.
Contrary to the above, the overwhelming majority of abdomi-
nal aortic aneurysms are of atherosclerotic origin and occur in
various sizes, shapes, and wall thicknesses. The layers are distorted
by atherosclerosis and mural thrombi are common, and because of
adherence, side branches, and frequent inflammatory response,
Figure 1. Reduction aortoplasty. An oval segment is ex
reducing its diameter to normal (A), and then the aortoto
nonabsorbable suture (B).they might be difficult to isolate during surgical intervention.
The Journal of ThoraciThese differences make RAA suitable for the treatment of
AscAs but much less likely for the treatment of aortic aneurysms
at other locations.
Surgical Technique
RAA consists of the excision of an oval segment of the anterior or
anterolateral ascending aortic wall in the axial direction, with the
aim of reducing its caliber to a normal level. The operation is
commonly done in combination with aortic valve replacement and
might be supplemented with circumferential external reinforce-
ment (wrap) with synthetic materials. Although RAA can be
performed by using side clamping of the ascending aorta,10 in all
but a few cases, appropriate diameter reduction requires an open
technique. Other types of ascending aortoplasties include partial
replacement,11 limited resection with end-to-end anastomosis,12,13
plication,14 plication-like procedures,15-18 or any combination of
these. External reinforcement can also be performed without
RAA.19-24
Femoral or axillary arterial cannulation might make the aortic
arch less crowded and the operation simpler. Dissection of the
ascending aorta is carried out off pump, with the heart beating, to
reduce bypass time. After institution of cardiopulmonary bypass,
the aortotomy is performed following the greater curvature of the
aorta, which is more often than not toward the right of the midline.
The incision should begin just proximal of the crossclamp and
extend into the noncoronary sinus. Scoring the aorta with a mark-
ing pen before crossclamping will ensure symmetric excision and
undistorted closure. When indicated, the aortic valve is replaced
first, followed by excision of a semielliptical portion of the aortic
wall on both sides of the aortotomy, reducing the aortic diameter
to about 3.5 cm when closed (Figure 1).
When a surgeon decides to reinforce the RAA, an oversized
of the maximal convexity of the ascending aorta, thus
s closed with a running mattress and an over-and-overcised
my iDacron vascular prosthesis is cut in length, split open longitudi-
c and Cardiovascular Surgery ● Volume 128, Number 4 563
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spare the origin of the innominate artery. Using the wrap with its
groves in the axial instead of the transverse direction or using a
knitted prosthesis25 will allow some aortic expansion, and for this
reason, it is discouraged. Materials such as polypropylene, ny-
lon,23,26 and knitted25 and woven Dacron23 have been used to
reinforce (wrap) the RAA. Of these, we found woven Dacron to be
the most suitable. The cardiac end of the wrap is anchored with
pledgeted sutures driven through the aortic wall inside out at the
right and the posterior commissure slightly anterior to the left
commissure and then tied over a second Teflon pledget, passed
through the wrap, and tied again (Figure 2, A). When the aortic
valve is replaced, these sutures are buttressed internally, not with
pledgets but with the sewing ring of the valve prosthesis (Figure 2,
B). After the aortotomy is closed with an over-and-over running
suture followed with a continuous mattress stitch, the patient is
weaned from cardiopulmonary bypass. The wrap is then tailored to
fit snugly but not too constricting. Small semicircles of wrap are
excised around the takeoff of the right and left coronary arteries to
avoid encroachment on the coronary orifices. The wrap is then
closed with a running, nonabsorbable suture (Figure 3, A and B).
If coronary bypass grafting is also required, the vein grafts
might be brought through the wrap through appropriately placed
27
Figure 2. Buttressing the proximal anchoring sutures with Teflon
pledgets (A) or, if the aortic valve is also replaced, with the
sewing ring of the valve prosthesis (B).openings (Figure 3, C). It has been suggested that complete
564 The Journal of Thoracic and Cardiovascular Surgery ● Octocoverage of the involved aortic segment, including the areas prox-
imal to the rise of the coronary arteries, is required to prevent
redilatation. In our view dissection and maneuvering of the wrap
around the coronary orifices is unnecessary because the area left
uncovered, being small and noncircumferential, will not dilate.
The event, which has been identified as “migration of the
wrap,” is a potential cause of aneurysm formation after reinforced
RAA.25,26,28 This can occur when areas of the aortic wall adjacent
to the wrap’s edge that were initially covered by the wrap become
exposed again. In our opinion this might happen not necessarily
through retraction of the wrap but rather because the aortic wall is
pulled out from under it by successive proximal or distal dilatation
of the aorta (Figure 4). Proximal anchoring and carrying the
reinforcement past the innominate artery will prevent such an
event (Figure 5).
Several modifications of the conventional RAA have been
recommended. Harrison and Heck,16 instead of removing an oval
piece of the aortic wall, decreased the aortic caliber by means of
open plication with a double suture line (shawl-aortoplasty).
Baumgartner and colleagues29 suggested that the aortotomy should
be S shaped rather than linear. Cotrufo and colleagues17,18 created
an arched, double-layer, autologous reinforcement of the right
lateral aspect of the aorta (waistcoat aortoplasty, Figure 6). Be-
cause wall stress in aneurysms is primarily circumferential, it is
dubious whether the risk of additional dilatation and eventual
rupture can be lowered by either of these techniques.
Review of the Literature
In 1956, Bahnson and Nelson10 used side clamping in 4 patients
with AscA and Marfan disease, excised a portion of the dilated
aorta, and enclosed the area of resection with a nylon binder. The
aorta in one patient (possibly others) was chronically dissected.
One patient was lost during surgical intervention, and 2 died 5 and
6 months later, respectively.
After Bahnson’s report, which, like many of his publications,
was way ahead of its time, the literature was silent on RAA for 13
years. In 1969, Jortner and associates30 presented a case of a child
with Marfan disease and acute dissection treated with “excision of
the aneurysm, endo-aneurysmorrhaphy and reinforcement of the
ascending aorta with a Dacron cuff.” It is unclear as to the nature
of the “endo-aneurysmorrhaphy,” but it is unlikely that the proce-
dure would qualify as an RAA in current terms. The situation was
similar in the Mayo Clinic’s series reported by McCready and
Pluth in 1969,31 in which 111 patients underwent aortic valve
replacement for regurgitation combined with repair of AscA. Fifty-
four percent of the patients had cystic medial necrosis, and 21%
had chronic dissection. Thirty-one of these had various forms of
nonreinforced “aortoplasties,” including patch repairs. The latter
group had a higher perioperative morbidity and mortality com-
pared with those treated with ascending aortic replacement. In the
“aortoplasty” group, there was also one late death caused by
rupture, and one intervention for redilatation.
Between 1969 and 1979, of 860 operations for a variety of
aortic aneurysms, we applied external reinforcement in 84 patients,
with a hospital mortality of 8%. During an observation period
extending up to 12 years, we encountered only a single case of
aortic rupture.24,32-34 Others19,23,35,36 had similar favorable expe-
37riences; however, Dhillon and coworkers and Smith and associ-
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complications, including rupture. Giving consideration to these
reports, we began to combine external reinforcement with RAA by
using the open technique and cardiopulmonary bypass. During the
Figure 3. Externally reinforced reduction aortoplasty. A
ascending aorta, which is already decreased in diamet
The Dacron wrap is tailored snug but not constricting,
with a running, nonabsorbable suture (B). Coronary bypa
Figure 4. Mechanisms of how aortic rupture might occ
might already be thin because of the dilatation (A), can
dilatation of the aorta distal to the uncovered segment
buckle and a spot of weakened resistance (arrow, C). Ryears of 1979 through 1994, we performed RAA in 28 patients
The Journal of Thoraciwith fusiform AscAs of moderate size (5.5 cm). Four of these
patients with Marfan disease had RAA only, and 24 had aortic
valve replacement as well. Two patients in the latter group died in
the hospital from causes unrelated to RAA.38 Only approximately
open Dacron vascular prosthesis is placed around the
te the presence of the proximal anchoring sutures (A).
ed past the origin of the innominate artery, and closed
afts can be brought through holes made in the wrap (C).
espite external reinforcement. The aortic wall, which
rgo additional under-the-wrap atrophy (B). Subsequent
t pull the aorta out from under the wrap and create a
re under the wrap can be caused by atrophy alone (D).cut-
er. No
carriur d
unde
mightwo thirds of the patients were followed past 5 years. Of these,
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able to aortic rupture, and 2 of unknown cause.38
During the following 2 decades, there were several additional
reports on RAAs. Some of the authors performed RAA
only,5,17,18,29,31,39,40 and others applied external reinforcement as
well, either selectively26,41 or in all of their patients.25,27 The
principal clinical data of these publications are condensed in Table
1.1,5,6,17,25-27,29,40-42
Survey
Questionnaires were sent to 5800 members of the Society of
Thoracic Surgeons and European Association for Cardio-thoracic
Surgery. We have received 867 (14.95%) responses. Of these, 646
(75.1%) were from the United States, and 221 (25.5%) were from
other countries. Five hundred eighty-nine (67.9%) of the 867 did
and 278 (32.1%) did not perform RAAs.
The 589 respondents performed 4436 RAAs altogether, and of
these, 2820 (63.6%) were done concomitantly with operations for
aortic stenosis, 1308 (29.4%) for aortic regurgitation, and 308
Figure 5. Completed externally reinforced ascending aortoplasty.
Preoperative (A) and postoperative (B) angiograms are shown in
the upper corner. (From Robicsek F. About ascending aortic
dilatation during aortic valve replacement. J Cardiovasc Surg
[Torino]. 2003;44:279; reproduced with permission.)(6.9%) as an independent procedure.
566 The Journal of Thoracic and Cardiovascular Surgery ● OctoInformation as to whether the RAA was reinforced was given
in 3312 (74.7%) cases; 1387 (41.7%) of these were reinforced, and
1925 (58.1%) were not. The late complications occurring in the
3312 patients are shown in Table 2.
Of 772 respondents, 414 (53.6%) believed that given specific
morphology, RAA is an appropriate procedure, whereas 343
(44.4%) thought that it should not be applied at all. Fifteen (1.94%)
had no opinion on the subject. Seven hundred sixty responded to
the question of whether the surgical mortality of RAA is expected
to be lower than that of more radical operations. Three hundred
sixty-two (47.6%) thought it was lower, 378 (49.7%) thought that
that it was not, and 20 (2.6%) had no opinion. Of 809 surgeons
responding on the subject of preoperatively known or suspected
Marfan disease, 594 (73.4%) regarded it as a contraindication of
RAA, 144 (17.8%) did not believe it to be a contraindication, and
71 (8.8%) had no opinion.
Discussion
In times when serious efforts are made to preserve the native aortic
valve, it appears illogical to discard the native ascending aorta. It
is intuitively obvious that it is desirable to leave the endothelium-
lined aorta where it is, reinforce it from the outside with a graft
inside the aorta, and then close the aorta around it.43 However, in
surgical intervention it is not always the most logical method that
necessarily provides the best results.
In the debate of RAA versus ascending aortic replacement,
issues of indication, the risks of the operation, and late complica-
tions seem to be most important.
The indication for RAA is greatly influenced by morphology.
Of the 3 principal forms of AscA—ie, poststenotic, annuloectatic
(marfanoid), and tubular—the poststenotic form, which represents
about 13% of all AscAs, appears most suitable for RAA, especially
if the patient who undergoes aortic valve replacement is elderly or
is at high risk for any other reason. In both the quoted literature and
in the survey, we found a general agreement that patients with
AscAs with a diameter of greater than 6 cm and those that are
saccular rather than fusiform, have significant dilatation of either
the annulus or sinuses, or both, should not undergo RAA.17,18,41 A
specific reason recommended for aortoplasty is that of Svensson
and colleagues,44 who applied it to patients likely to return for
additional procedures, such as coronary bypass grafting.
We were somewhat surprised that approximately half of the
surgeons in the survey expressed the view that the operative risks
of RAA are similar to those of more radical procedures, such as the
Bentall operation. This might be either an understatement or a
reflection of some superb clinical performances that could be
difficult to duplicate.45 Statistics of institutions with considerable
experience indicate that graft replacement of the ascending aorta
still remains a technical challenge entailing significant risk, with
perioperative mortality varying from 1.5% up to 10%.3,44-50
Immer and coworkers49 studied 73 patients who met the criteria
for RAA but underwent ascending aortic graft replacement instead.
The hospital’s mortality was 9.6%, the late mortality was 4%, and
neurologic complications occurred in 6.7% of the patients. Elefte-
riades3 found the risk of surgical mortality for AscA surgery to be
2.5% and the chance of perioperative stroke to be 8%, even in the
hands of the “most experienced operators.” In contrast, with a
ber 2004
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or mortality attributable to RAA per se has ever been reported.
To be fair, however, it needs to be emphasized that none of the
series comparing results of RAAs with those of more radical
procedures were ever randomized, and bias in selection is not only
likely but probable. The indication for RAA was limited to aneu-
rysms of moderate sizes,1,29,39,41 and in several series patients with
Marfan disease, dissection, or both were also exclud-
ed.17,18,25,27,29,41 Some authors, however, chose RAA for a par-
ticular patient because of the higher surgical risk of more complex
procedures.6,38
Because of a lack of procedural mortality and low morbidity in
comparing the merits and disadvantages of the two procedures,
long-term results are especially important. Estimation of these,
however, is difficult because of the various criteria applied by
different surgeons in both indication and technique. Thus it is
entirely possible that the occurrence of some late complications
(ie, redilatation and rupture) are not inherent to RAA but were
consequences of selection and technique. Because the majority of
our colleagues see it because patients with Marfan disease tend to
redilate in the absence of external support, the presence of any
genetic disorder of the aortic wall should contraindicate use of
unsupported RAA.
For all practical reasons, the above considerations leave only
AscAs induced by aortic stenosis (poststenotic type) suitable for
unsupported RAAs.1,5 In patients with aortic regurgitation, more
often than not the sinuses are enlarged, the dilatation of the
ascending aorta is tubular, the dilatation might extend beyond the
origin of the innominate artery, and the aortic wall tends to be
Figure 6. Different aortoplasty closures: Robicsek (A),5
Baumgartner and associates (D).29thinner and more friable. For these reasons, aortic regurgitation
The Journal of Thoraciappears to be a risk factor per se for redilatation after unsupported
RAA.5 On the other hand, implantation of a prosthetic aortic valve
favorably influences the outcome of RAA by stabilizing the aortic
orifice and facilitating proximal anchoring.
The applicability of reinforced RAA is broader because, given
proper technique, redilatation of the ascending aorta is less likely
to occur, even in patients with cystic medial necrosis. For this
reason, in the past, we38,51 and others1,25,27 have advocated that all
RAAs should be externally reinforced. In young individuals with
known Marfan disease and mild (3.5-4 cm) ascending aortic dila-
tation, it would seem reasonable to treat these aortas with rein-
forced RAA because of the hazard of dissection.38 Such an early
approach would also prevent the development of aortic regurgita-
tion, which is usually caused by dilatation of the ascending aorta.52
The application of reinforced RAA in such patients, however, now
needs to be reconsidered in view of sporadic reports indicating that
occasional rupture after RAA might occur despite external rein-
forcement.28,53
The article by Neri and colleagues,53 published in 1990, de-
scribes two patients who, after having undergone aortic valve
replacement and reinforced RAA 7 and 11 years previously, re-
quired reoperation because of development of false aneurysms.
The unwrapped parts of the ascending aorta in both patients
appeared normal; conversely, the aortic wall underlying the wrap
was severely atrophic, a phenomenon previously reported with
abdominal aneurysms that were wrapped without aortoplasty.20,37
In both cases rupture occurred on the posterior aspect of the
wrapped aorta distant to the aortotomy suture line. Atrophy under
the wrap has also been reported by Bauer and coworkers28 in a
rison and Heck (B),16 Cotrufo and colleagues (C),18 and1 Har53-year-old patient who underwent aortic valve replacement and
c and Cardiovascular Surgery ● Volume 128, Number 4 567
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because of perivalvular leak and left main coronary artery disease.
TABLE 1. Literary review
Author
No. of patients Aorto
Not
reinforced Reinforced
RAA
only
Egloff and coworkers
(1982)26
21 17 –
Mueller and coworkers
(1997)5
15 – –
Carrel and coworkers
(1991)1
164 – –
Barnett and coworkers
(1995)6
9 8 1
Ogus and coworkers
(2002)25
– 22 –
Baumgartner and
coworkers (1998)29
23 – –
Bauer and coworkers
(2002)41
106 9 7
Cotrufo and coworkers
(2001)17,18
73 – –
Oelert (2003)42 – 43 –
Tsilimingas and Reiter
(2003)27
– 26 –
Kamada and coworkers
(2003)40
10 – –
RAA, Reduction ascending aortoplasty.
TABLE 2. Complications noted
Redilatation only
Nonreinforced 136 (7.1%)
Reinforced 62 (4.5%)
Rupture
Nonreinforced 67 (3.9%)
Reinforced 21 (1.5%)They found “that the Dacron wrapping had moved to the distal part
568 The Journal of Thoracic and Cardiovascular Surgery ● Octoof the ascending aorta, creating a sharp fold at the inner curve.”
Although the aorta did not rupture, there was rarefaction of the
aortic wall in the region of the fold to a degree that tissue of the
Dacron material was clearly visible through the remnants of the
aortic wall. The participants in our survey also reported a relatively
small number (approximately 1.1%) of late ruptures with rein-
forced aortoplasty. It is not clear whether these ruptures were
inevitable or were caused by less-than-appropriate technique.
Conclusions and Summary
The value of conclusions drawn from our data are limited by the
y
Follow-up
No. of
redilatations Notes
aortic
ve
ery
9 45 mo 8 All 3 redilatations in the
reinforced group were
caused by
“displacement of
Nylon-net,” 2 had
Marfan syndrome. Five
nonreinforced cases
were redilated. There
were 4 late deaths
(caused by rupture?)
5 6 y 4 All redilatations were in
patients with Marfan
syndrome and who
underwent operations
for aortic regurgitation.
4 6 y 6
7 4.4 y – There were 3 early and 2
late deaths, none of
which were related to
aortoplasty.
2 4 y –
1 1.3  0.8
y
– There was 1 coronary
bypass and 1 subaortic
stenosis.
9 2 y 9 All redilatations were
nonreinforced, and the
postreduction diameter
was 36.6  3.4 mm
3 2 y –
2 10 y –
6 28 mo –
0 3 y 1plast
With
val
surg
2
1
16
1
2
2
10
7
2
2
1lack of prospective design. Also, although in some of the studies
ber 2004
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randomized. Bias was not only present but also bidirectional; in
some series only patients with the highest surgical risk were
selected, whereas others also included those with the lowest risk
factors.
The material presented, however, still allows the following
statements to be made:
1. RAA is certainly alive. Although it does not appear to be an
extremely popular operation, about half of the surgeons who
responded believe it to be justified.
2. Given proper indications (ie, poststenotic dilatations of 6
cm in diameter, absence of cystic medial necrosis, and a
technique that decreases aortic diameter to 3.5 cm), non-
reinforced RAA performed concomitantly with aortic valve
replacement appears to be a simple and safe procedure, with
low morbidity and mortality and rare late complications.
3. External reinforcement might extend the scope of indication
for RAA to AscAs associated with aortic regurgitation and to
those with primary structural aortic wall disease with com-
parable results. Experience also has shown that late compli-
cations might be further reduced by proper proximal anchor-
ing and extending the wrap past the origin of the innominate
artery.
4. Regardless of which modality is used, lifetime monitoring of
ascending aortic size is essential and so advised.
5. Because of recent sporadic reports of “under-the-wrap” aor-
tic wall atrophy and rupture, the issue of reinforcement of
RAA needs continued re-evaluation.
References
1. Carrel T, von Segesser L, Jenni R, et al. Dealing with dilated ascending
aorta during aortic valve replacement: advantages of conservative
surgical approach. Eur J Cardiothorac Surg. 1991;5:137-43.
2. Robicsek F, Thubrikar MJ. The mechanism and prevention of aortic
dissection in Marfan syndrome. In: Hetzer R, Gehle P, Ennker J,
editors. Cardiovascular aspects of Marfan syndrome. Darmstadt, Ger-
many: Steinkopff Verlag GmbH & Co KG; 1995.
3. Elefteriades J. Natural history of thoracic aortic aneurysms: indications
for surgery and surgical versus nonsurgical risks. Ann Thorac Surg.
2002;74(suppl):S1877-98.
4. Robicsek F. “Very long” aortic grafts. Eur J Cardiothorac Surg.
1992;6:536-41.
5. Mueller X, Tevaearai H, Genton C, et al. Drawback of aortoplasty for
aneurysm of the ascending aorta associated with aortic valve disease.
Ann Thorac Surg. 1997;63:762-7.
6. Barnett M, Fiore A, Vaca K, Milligan T, Barner H. Tailoring aorto-
plasty for repair of fusiform ascending aortic aneurysms. Ann Thorac
Surg. 1995;59:497-501.
7. Robicsek F, Thubrikar MJ, Cook JW, Fowler B. The congenitally
bicuspid aortic valve. How does it function? Why does it fail. Ann
Thorac Surg. 2004;77:177-85.
8. Natsuaki M, Itoh T, Rikitake K, Okazaki Y, Naitoh K. Aortic com-
plications after aortic valve replacement in patients with dilated as-
cending aorta and aortic regurgitation. J Heart Valve Dis. 1998;7:
504-9.
9. Fedak P, Mauro P, Verma S, et al. Vascular matrix remodeling in
patients with bicuspid aortic valve malformations: implications for
aortic dilatation. J Thorac Cardiovasc Surg. 2003;126:797-805.
10. Bahnson HT, Nelson AR. Cystic medial necrosis as a cause of local-
ized aortic aneurysms amenable to surgical treatment. Ann Surg.
1956;144:519-29.
11. Westaby S, Katsumata T, Vaccari G. Coronary reimplantation in aortic
root replacement: a method to avoid tension. Ann Thorac Surg. 1999;
67:1176-7.
The Journal of Thoraci12. Sternik L, Zehr KJ, Schaff HV. A method of repair for asymmetric
aneurysmal dilatation of the ascending aorta. Ann Thorac Surg. 2002;
73:1332-4.
13. Vigano M, Rinaldi M, D’Armini AM, et al. Ascending aortic aneu-
rysms treated by cuneiform resection and end-to-end anastomosis
through a ministernotomy. Ann Thorac Surg. 2002;74(suppl):S1789-
92.
14. Albes J, Wahlers T. Valve-sparing root reduction plasty in aortic
aneurysm: the “Jena” technique. Ann Thorac Surg. 2003;75:1031-3.
15. Frater R. Aortic insufficiency due to aortic dilatation correction by
sinus rim adjustment. Circulation. 1986;74(suppl I):I136.
16. Harrison LJ, Heck HJ. Shawl lapel aortoplasty. Ann Thorac Surg.
1996;62:1867.
17. Cotrufo M, De Santo L, Esposito S, et al. Asymmetric medial degen-
eration of the intrapericardial aorta in aortic valve disease. Int J Car-
diol. 2001;81:37-41.
18. Cotrufo M, Della Corte A, De Santo L, De Feo M, Covino F, Dialetto
G. Asymmetric medial degeneration of the ascending aorta in aortic
valve disease: a pilot study of surgical management. J Heart Valve Dis.
2003;12:127-35.
19. Buxton B, Harlan B. Surgical treatment of fusiform thoracic aortic
aneurysms by external reinforcement. Bull Texas Heart Inst Cardio-
vasc Dis. 1976;3:35.
20. Smith RI, Constantino M, Perdue GJ. Is there a place for external
grafting of arterial aneurysms in selected patients? J Cardiovasc Surg
(Torino). 1979;20:13-20.
21. McAllister FF. Discussion. Robicsek F, Daugherty HK, Mullen DC,
Harbold NB Jr, Masters TN. Is there a place for wall reinforcement in
modern aortic surgery? Arch Surg. 1972;105:827-9.
22. Long E. Discussion. Robicsek F, Daugherty HK, Mullen DC, Harbold
NB Jr, Masters TN. Is there a place for wall reinforcement in modern
aortic surgery? Arch Surg. 1972;105:824-9.
23. Milgalter E, Laks H. Dacron mesh wrapping to support the aneurys-
mally dilated or friable ascending aorta. Ann Thorac Surg. 1991;52:
874-6.
24. Robicsek F, Daugherty K, Mullen DC, Harbold NB Jr, Masters TN. Is
there a place for wall reinforcement in modern aortic surgery? Arch
Surg. 1972;105:827-9.
25. Ogus N, Cicek S, Isik O. Selective management of high risk patients
with an ascending aortic dilatation during aortic valve replacement.
J Cardiovasc Surg (Torino). 2002;43:609-15.
26. Egloff L, Rothlin M, Kugelmeier J, Senning A, Turina M. The as-
cending aortic aneurysm: replacement or repair? Ann Thorac Surg.
1982;34:117-24.
27. Tsilimingas N, Reiter B. Repair of ascending aorta using a new
modification of wrapping. The “external circuit.” Ann Thorac Surg.
2004. In press.
28. Bauer M, Grauhan O, Hetzer R. Dislocated wrap after previous reduc-
tion aortoplasty causes erosion of the ascending aorta. Ann Thorac
Surg. 2003;75:583-4.
29. Baumgartner F, Omari B, Pak S, Ginzton L, Shapiro S, Milliken J.
Reduction aortoplasty for moderately sized ascending aortic aneu-
rysms. J Card Surg. 1998;13:129-32.
30. Jortner R, Shahin W, Eshkol D, Gueron M, Levy M. Cardiovascular
manifestations and surgery for Marfan’s syndrome. Dis Chest. 1969;
56(1):24-30.
31. McCready R, Pluth J. Surgical treatment of ascending aortic aneu-
rysms associated with aortic valve insufficiency. Ann Thorac Surg.
1979;28:307-16.
32. Robicsek F, Daugherty HK, Mullen DC. External grafting of aortic
aneurysms. J Thorac Cardiovasc Surg. 1971;61:131-4.
33. Robicsek F, Perkins RS, Mullen DC, Daugherty HK, Harbold NB Jr.
Fusiform aneurysm of the entire aortic arch. A new surgical approach.
J Thorac Cardiovasc Surg. 1972;63:756-9.
34. Robicsek F, Daugherty HK, Mullen DC, et al. Long-range observa-
tions with external aortic grafts. J Cardiovasc Surg (Torino). 1976;17:
195-201.
35. Tanabe T, Kubo Y, Hashimoto M, Takahashi T, Yasuda K, Surgie S.
Wall reinforcement with highly porous Dacron mesh in aortic surgery.
Ann Surg. 1980;191:452-5.36. Ando M, Okita Y, Morota T, Takamoto S. Thoracic aortic aneurysm
c and Cardiovascular Surgery ● Volume 128, Number 4 569
Surgery for Acquired Cardiovascular Disease Robicsek et al
A
CDassociated with congenital bicuspid aortic valve. Cardiovasc Surg.
1998;6:629-34.
37. Dhillon J, Randhawa G, Straehley C, McNamara J. Late rupture after
Dacron wrapping of aortic aneurysms. Circulation. 1986;74(suppl):
I11-4.
38. Robicsek F, Thubrikar MJ. Conservative operation in the management
of annular dilatation and ascending aortic aneurysm. Ann Thorac Surg.
1994;57:1672-4.
39. Baumgartner F, Pak S, Ginzton L, Milliken J. Reduction aortoplasty
for moderate-sized ascending aortic aneurysms. Ann Thorac Surg.
1995;59:268.
40. Kamada T, Imanaka K, Ohuchi H, et al. Mid-term results of aorto-
plasty for dilated ascending aorta associated with aortic valve disease.
Ann Thorac Cardiovasc Surg. 2003;9:253-6.
41. Bauer M, Pasic M, Schaffarzyk R, et al. Reduction aortoplasty for
dilatation of the ascending aorta in patients with bicuspid aortic valve.
Ann Thorac Surg. 2002;73(3):720-4.
42. Oelert H. Aortoplasty and wrapping for aneurysms of the ascending
aorta. Presented at the Italian Conference of Cardiovascular Disease;
April 10-15, 2003; Erice, Italy.
43. Kouchoukos N. Aortic graft-valve (composite) replacement at 20
years: wrap or no wrap? Shunt or no shunt? Ann Thorac Surg.
1989;48:615-6.
44. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Composite
valve graft replacement of the proximal aorta: comparison of tech-
niques in 348 patients. Ann Thorac Surg. 1992;54:427-438.570 The Journal of Thoracic and Cardiovascular Surgery ● Octo45. Gott VL. Invited commentary. Robicsek F, Thubrikar MJ. Conserva-
tive operation in the management of annular dilatation and ascending
aortic aneurysm. Ann Thorac Surg. 1994;57:1674.
46. Hilgenberg AD, Akins CW, Logan DL, et al. Composite aortic root
replacement with direct coronary artery implantation. Ann Thorac
Surg. 1996;62:1090-5.
47. David T. Invited commentary. J Heart Valve Dis. 2003;12(2):127-
35.
48. Jault F, Nataf P, Rama A, et al. Chronic disease of the ascending aorta.
Surgical treatment and long-term results. J Thorac Cardiovasc Surg.
1994;108:747-54.
49. Immer FF, Barmettler H, Berdat PA, et al. Effects of deep hypothermic
circulatory arrest on outcome after resection of ascending aortic an-
eurysm. Ann Thorac Surg. 2002;74:422-5.
50. Kon ND, Riley RD, Adair SM, Kitzman DW, Cordell AR. Eight-year
results of aortic root replacement with the freestyle stentless porcine
aortic root bioprosthesis. Ann Thorac Surg. 2002;73:1817-1821.
51. Robicsek F. A new method to treat fusiform aneurysms of the ascend-
ing aorta associated with aortic valve disease: an alternative to radical
resection. Ann Thorac Surg. 1982;34:92-4.
52. Griepp R. Ascending aorta. Presented at the Aortic Surgery Sympo-
sium VIII; May 2-3, 2002; New York.
53. Neri E, Massetti M, Tanganelli P, et al. Is it only a mechanical matter?
Histologic modifications of the aorta underlying external banding.
J Thorac Cardiovasc Surg. 1999;118:1116-8.ber 2004
